Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

BUY
$1.66 - $2.31 $1,142 - $1,589
688 Added 1.11%
62,445 $138,000
Q2 2023

Aug 01, 2023

BUY
$1.61 - $1.96 $31,073 - $37,828
19,300 Added 45.46%
61,757 $114,000
Q1 2023

Apr 27, 2023

BUY
$1.8 - $2.83 $2,120 - $3,333
1,178 Added 2.85%
42,457 $82,000
Q4 2022

Feb 07, 2023

BUY
$2.05 - $5.5 $3,103 - $8,327
1,514 Added 3.81%
41,279 $101,000
Q3 2022

Nov 07, 2022

BUY
$0.94 - $5.99 $112 - $718
120 Added 0.3%
39,765 $197,000
Q2 2022

Jul 28, 2022

BUY
$3.2 - $5.69 $126,864 - $225,580
39,645 New
39,645 $186,000

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.